Nkarta Inc. (NKTX) Social Stream



Nkarta Inc. (NKTX): $2.45

0.01 (+0.41%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add NKTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#324 of 334

in industry

NKARTA INC (NKTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NKARTA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-10 4 $77 $71 $74.333 $10.2 628.75%
2021-11-16 4 $75 $71 $72.333 $10.2 609.15%
2021-11-18 5 $75 $50 $66.75 $10.2 554.41%
2022-03-18 8 $50 $17 $37.4 $10.2 266.67%
2022-03-29 8 $71 $17 $43 $10.2 321.57%
2022-04-01 8 $71.001 $17 $43 $10.2 321.57%
2022-05-13 8 $60 $32 $44.333 $10.2 334.64%
2022-07-18 9 $60 $30 $42.285 $10.2 314.56%
2022-08-12 11 $50 $26 $37.428 $10.2 266.94%
2022-10-14 11 $50 $25 $35.875 $10.2 251.72%
2022-11-10 11 $50 $25 $33.875 $10.2 232.11%
2022-11-16 12 $38 $25 $30.875 $10.2 202.7%
2022-12-05 11 $38 $25 $30.555 $10.2 199.56%
2023-03-16 10 $38 $25 $30.142 $10.2 195.51%
2023-03-17 10 $32 $21 $27.142 $10.2 166.1%
2023-04-18 10 $32 $21 $26.857 $10.2 163.3%
2023-06-02 9 $32 $18 $26.428 $10.2 159.1%
2023-06-28 9 $26 $13 $19.857 $10.2 94.68%
2023-08-11 9 $26 $13 $18.857 $10.2 84.87%
2023-09-28 9 $25 $13 $16.285 $10.2 59.66%
2023-10-17 9 $16 $13 $14.833 $10.2 45.42%
2023-10-19 9 $15 $10 $13.833 $10.2 35.62%
2023-11-10 9 $15 $10 $13.428 $10.2 31.65%
2023-11-16 9 $15 $9 $12.571 $10.2 23.25%

The Trend in the Analyst Price Target


Over the past 40 months, NKTX's average price target has gone down $30.83.

Over the past 35 weeks, NKTX's average upside potential has been 593.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-31 10 32 21 26.857 3.550 656.54%
2023-06-28 9 26 13 19.857 2.480 700.69%
2023-09-28 9 16 13 14.833 1.500 888.87%
2023-10-17 9 16 13 14.833 3.140 372.39%
2023-11-16 9 15 9 12.571 2.355 433.8%

NKTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.13 7 1 0 0 0 8

The Trend in the Broker Recommendations


Over the past 153 days, NKTX's average broker recommendation rating improved by 0.11.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • NKARTA INC's upside potential (average analyst target price relative to current price) is higher than 3630.47% of all US stocks.
  • In the context of all US stocks, NKARTA INC's variance in analysts' estimates is lower than -2552.71% of them.
  • NKTX has a greater number of analysts covering the stock than 2614.71% of stocks in the mid market cap category.
  • NKTX has a greater average analyst price target than 1988.31% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NKARTA INC are ALXO, STTK, and PRAX.

Make investment decisions regarding NKTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!